Press Release

View printer-friendly version

<<  Back

Geron Announces November Investor Conference Presentation Webcasts

MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences:

  • Stifel 2017 Healthcare Conference in New York at 4:15 p.m. ET on Tuesday, November 14, 2017.
  • Piper Jaffray 29th Annual Healthcare Conference in New York at 3:30 p.m. ET on Tuesday, November 28, 2017.

A live audio webcast of each presentation will be available through the Investors section of Geron’s website ( under Events. Following the live presentations, the webcasts will be archived and available for replay for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations

Geron Corporation